Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients

Lung Cancer

Volumn 44, Issue 3, 2004, Pages 303-310

  Guadagni, F ^a   Ferroni, P ^b   Basili, S ^b   Facciolo, F ^a   Carlini, S ^a   Crecco, M ^a   Martini, F ^b   Spila, A ^a   D'Alessandro, R ^a   Aloe, S ^a   Cerasoli, V ^a   Del Monte, G ^a,c   Mariotti, S ^c   Mineo, T C ^c   Roselli, M ^c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Coagulation; D Dimer; Fibrinolysis; Non small cell lung cancer; Thrombin antithrombin complexes; Tumor necrosis factor alpha

Indexed keywords

D DIMER; INTERLEUKIN 6; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FIBRINOLYSIS; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BLOOD COAGULATION; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEPTIDE HYDROLASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342582692     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.11.009     Document Type: Article

References (31)

1. Rickles FR, Levine MN, Dvorak HF, Abnormalities of hemostasis in malignancy. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and thrombosis. Basic principles and clinical practice, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1131-52.
2. van Wersch J.W., Tjwa M.K. Coagulation/fibrinolysis balance and lung cancer. Haemostasis. 21:1991;117-123
3. Gabazza E.C., Taguchi O., Yamakami T., Machishi M., Ibata H., Suzuki S. Evaluating prethrombotic state in lung cancer using molecular markers. Chest. 103:1993;196-200
4. Matsuyama W., Hashiguchi T., Mizoguchi A., Iwami F., Kawabata M., Arimura K., et al. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer. Chest. 118:2000;948-951
5. Roselli M., Mineo T.C., Basili S., Mariotti S., Martini F., Bellotti A., et al. Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers. Thromb Haemost. 89:2003;177-184
6. Pavey S.J., Hawson G.A., Marsh N.A. Alterations to the fibrinolytic enzyme system in patients with non-small cell lung carcinoma. Blood Coagul Fibrinolysis. 10:1999;261-267
7. Seitz R., Rappe N., Kraus M., Immel A., Wolf M., Maasberg M., et al. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagul Fibrinolysis. 4:1993;249-254
8. Taguchi O., Gabazza E.C., Yasui H., Kobayashi T., Yoshida M., Kobayashi H. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 52:1997;563-565
9. Ferrigno D., Buccheri G., Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur. Respir. J. 17:2001;667-673
10. Pavey S.J., Hawson G.A., Marsh N.A. Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma. Blood Coagul. Fibrinolysis. 12:2001;51-58
11. Gabazza E.C., Taguchi O., Yamakami T., Machishi M., Ibata H., Tsutsui K., et al. Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer. Cancer. 70:1992;2631-2636
12. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 357:2001;539-545
13. Li R, Rüttinger D, Li R, Si LS, Wang YL, Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer, Langenbecks Arc Surg 2003;388:406-12.
14. Ardizzoia A., Lissoni P., Brivio F., Tisi E., Perego M.S., Grassi M.G., et al. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J. Biol. Regul. Homeost Agents. 6:1992;103-107
15. Matanic D., Beg-Zec Z., Stojanovic D., Matakoric N., Flego V., Milevoj-Ribic F. Cytokines in patients with lung cancer. Scand J. Immunol. 57:2003;173-178
16. Aleman M.R., Santolaria F., Batista N., de La Vega M., Gonzalez-Reimers E., Milena A., et al. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine. 19:2002;21-26
17. Stouthard J.M., Levi M., Hack C.E., Veenhof C.H., Romijn H.A., Sauerwein H.P., et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 76:1996;738-742
18. Zwaveling J.H., Maring J.K., Mulder A.B., Bom V.J., van Ginkel R.J., Schraffordt Koops H., et al. Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha and melphalan on the human fibrinolytic system. Cancer Res. 56:1996;3948-3953
19. Suharti C., van Gorp E.C., Setiati T.E., Dolmans W.M., Djokomoeljanto R.J., Hack C.E., et al. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Haemost. 87:2002;42-46
20. ten Cate J.W., van der Poll T., Levi M., ten Cate H., van Deventer S.J.H. Cytokines: triggers of clinical thrombotic disease. Thromb Haemost. 78:1997;415-419
21. Van Deventer S.J.H., Buller H.R., ten Cate J.W., Aarden L.A., Hack C.E., Sturk A. Experimental endotoxinaemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 76:1990;2520-2526
22. van der Poll T., Levi M., Buller H.R., van Deventer S.J., de Boer J.P., Hack C.E., et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J. Exp. Med. 174:1991;729-732
23. van der Poll T., Levi M., van Deventer S.J.H., ten Cate H., Haagmans B.L., Biemond B.J., et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood. 83:1994;446-451
24. van der Poll T., Coyle S.M., Levi M., Jansen P.M., Dentener M., Barbosa K., et al. Effect of recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood. 89:1997;3727-3734
25. Nakstad B., Lyberg T., Skjonsberg O.H., Boye N.P. Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res. 57:1990;827-838
26. Alessandri C., Basili S., Violi F., Ferroni P., Gazzaniga P.P., Cordova C. C.O.B.H. Group Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemost. 72:1994;343-346
27. Davì G., Basili S., Vieri M., Cipollone F., Santarone S., Alessandri C., et al. C.O.B.H. Group Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care Med. 156:1997;1794-1799
28. Ferroni P., Basili S., Martini F., Vieri M., Labbadia G., Cordova C., et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J. Invest Med. 48:2000;21-27
29. Keller T., Salge U., Konig H., Dodt J., Heiden M., Seitz R. Tissue factor is the only activator of coagulation in cultured human lung cancer cells. Lung Cancer. 31:2001;171-179
30. Rickles F.R., Shoji M., Abe K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int. J. Hematol. 73:2001;145-150
31. Nakasaki T., Wada H., Shigemori C., Miki C., Gabazza E.C., Nobori T., et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am. J. Hematol. 69:2002;247-254